other material
confidence high
sentiment positive
materiality 0.60
Vaxcyte raises $600.2M in public offering of 12.65M shares at $50/share
Vaxcyte, Inc.
- Offering of 11M shares at $50.00 public price; underwriter option for 1.65M shares exercised.
- Net proceeds of approximately $600.2M after underwriting discounts and expenses.
- Underwriters purchased shares at $47.50 each; offering closed on February 2, 2026.
- Proceeds will support general corporate purposes, including pipeline development.